Schizophrenia adherence therapy improves symptoms, not adherence

From Clinical Psychiatry News, 23 April 2013: Adherence therapy improves symptoms in patients with schizophrenia but does not appear to affect adherence, treatment attitudes. or functioning, according to results of a randomized controlled trial. “We observed a small effect of AT [adherence therapy] on patient symptoms but not adherence, treatment attitudes, or functioning following an Continue reading Schizophrenia adherence therapy improves symptoms, not adherence

Continued engagement with schizophrenia patients can prevent declines

From Clinical Psychiatry News, 23 April 2013: A review of the causes and impact of hospitalization in schizophrenia has shown that hospitalization is more likely the result of cognitive and functional decline rather than a contributor. “While it is difficult to disentangle the consequence of the reasons for hospitalization from the effects of hospitalization, most Continue reading Continued engagement with schizophrenia patients can prevent declines

Neuroimaging reveals characteristics of deficit schizophrenia

From Clinical Psychiatry News, 19 March 2013: The deficit subtype of schizophrenia is characterized by white matter tract disruption, while all subtypes of schizophrenia feature a reduction in cortical thickness, a cross-sectional neuroimaging study has found. Patients with deficit schizophrenia showed significant disruption of white matter at the right inferior longitudinal fasciculus, the right arcuate Continue reading Neuroimaging reveals characteristics of deficit schizophrenia

Genotype plays role in schizophrenia response to folate

From Clinical Psychiatry News, 19 March 2013: Folate and vitamin B12 supplements may improve the negative symptoms of schizophrenia but only in patients with a genetic variant that influences folate metabolism, a study has shown. “Although four such variants have previously been associated with negative symptom severity, the genotype that contributed most strongly to treatment Continue reading Genotype plays role in schizophrenia response to folate